These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9924214)

  • 1. Increased erythrocyte aggregation as an indicator for an aggressive clinical course in Behçet's disease: a prospective study.
    Demiroğlu H; Yalçin S; Büyükaşik Y; Ozcebe OI; Dündar S
    Ann Rheum Dis; 1998 Nov; 57(11):694-6. PubMed ID: 9924214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte aggregation in Behçet's disease determined with the Sefam and Myrenne aggregometer. Lack of association with thrombosis and uveitis.
    Ricart JM; Vayá A; Todolí J; Santaolaria ML; Calvo J; Aznar J
    Clin Hemorheol Microcirc; 2005; 33(4):389-96. PubMed ID: 16317248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
    Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
    Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
    Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
    Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemorheological alterations in Behçet's disease are not related to a tendency for venous thrombosis.
    Ricart JM; Vaya A; Todolí J; Calvo J; Contreras MT; España F; Aznar J; Corella D
    Thromb Res; 2005; 115(5):399-404. PubMed ID: 15810159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Mean Platelet Volume in Patients With Behcet's Disease as an Indicator of Vascular Thrombosis.
    Ataş H; Canpolat F; Eskioglu F
    Arch Iran Med; 2018 Jun; 21(6):234-239. PubMed ID: 29940741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte deformability does not seem to be altered in Behçet's disease.
    Simó M; Ricart JM; Santaolaria M; Ortí G; Vayá A
    Clin Hemorheol Microcirc; 2007; 36(1):83-8. PubMed ID: 17211064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could be serum uric acid a risk factor for thrombosis and/or uveitis in Behcet's disease?
    Atıl A; Deniz A
    Vascular; 2018 Aug; 26(4):378-386. PubMed ID: 29360007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased mean platelet volume in Behçet's disease with thrombotic tendency.
    Acikgoz N; Karincaoglu Y; Ermis N; Yagmur J; Atas H; Kurtoglu E; Cansel M; Barutcu I; Pekdemir H; Ozdemir R
    Tohoku J Exp Med; 2010 Jun; 221(2):119-23. PubMed ID: 20484842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased erythrocyte deformability in Behçet's disease.
    Usküdar O; Erdem A; Demiroğlu H; Dikmenoğlu N
    Clin Hemorheol Microcirc; 2005; 33(2):89-94. PubMed ID: 16151256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease.
    Er H; Evereklioglu C; Cumurcu T; Türköz Y; Ozerol E; Sahin K; Doganay S
    Br J Ophthalmol; 2002 Jun; 86(6):653-7. PubMed ID: 12034688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhomocysteinaemia is associated with uveitis but not with deep venous thrombosis in Behcet's disease.
    Feki M; Houman H; Ghannouchi M; Smiti-Khanfir M; Hamzaoui K; El Matri L; Mebazaa A; Kaabachi N
    Clin Chem Lab Med; 2004; 42(12):1417-23. PubMed ID: 15576305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behçet's disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients.
    Houman MH; Neffati H; Braham A; Harzallah O; Khanfir M; Miled M; Hamzaoui K
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S58-64. PubMed ID: 17949553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease?
    Keskin D; Keskin G; Inal A; Ozışık L
    Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
    Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
    Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinaemia in Behçet's disease.
    Aksu K; Turgan N; Oksel F; Keser G; Ozmen D; Kitapçioğlu G; Gümüşdiş G; Bayindir O; Doğanavşargil E
    Rheumatology (Oxford); 2001 Jun; 40(6):687-90. PubMed ID: 11426028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between deep vein thrombosis and erythema nodosum in male patients with Behçet's disease.
    Cebeci F; Onsun N; Ulusal HA; Inan B
    Eur Rev Med Pharmacol Sci; 2014; 18(21):3145-8. PubMed ID: 25487921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced erythrocyte deformability in active and untreated Behçet's disease patients.
    Tatlican S; Duran FS; Eren C; Eskioglu F; Dikmenoglu N; Oktay B; Durmazlar SP; Canpolat F
    Int J Dermatol; 2010 Feb; 49(2):167-71. PubMed ID: 20465640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.